LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis

Photo by atikahakhtar from unsplash

GP2015 is a proposed etanercept biosimilar. Click to show full abstract

GP2015 is a proposed etanercept biosimilar.

Keywords: proposed etanercept; etanercept biosimilar; gp2015 proposed; study; egality study; study confirmatory

Journal Title: British Journal of Dermatology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended


                Click one of the above tabs to view related content.